Misonix to Report on 3rd-Quarter Results

Misonix, Inc., a surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for wound debridement, spinal surgery, cosmetic surgery, neurosurgery, laparoscopic surgery and other surgical applications, announced today that it will report financial results for the third fiscal quarter ended March 31, 2012 on Wednesday, May 9.

The company has scheduled a conference call that same day, Wednesday, May 9, 2012, at 4:30 pm ET to review the results.

Interested parties can access the conference call by dialing (877) 317-6789 or (412) 317-6789 or can listen via a live Internet webcast, which is available in the Investor Relations section of the Company's website at www.misonix.com .

A teleconference replay of the call will be available for three days at (877) 344-7529 or (412) 317-0088, confirmation #10013750. A webcast replay will be available in the Investor Relations section of the Company's website at www.misonix.com for 30 days.

Misonix, Inc. designs, develops, manufactures and markets therapeutic ultrasonic surgical devices. Misonix's therapeutic ultrasonic platform is the basis for several innovative medical technologies. Addressing a combined market estimated to be in excess of $3 billion annually, Misonix's proprietary ultrasonic medical devices are used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications. Additional information is available on the Company's Web site at www.misonix.com .